World Health Organization. World report on ageing and health. Geneva: WHO; 2015.

Hugo J, Ganguli M. Dementia and cognitive impairment. Clin Geriatr Med 2014 ;30:421–42. doi: 10.1016/j.cger.2014.04.001.

Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population based perspective. Alzheimers Dement 2015;11:718–26. doiI: 10.1016/j.jalz.2015.05.016.

Direktorat Statistik Kesejahteraan Rakyat. Statistik Penduduk Lanjut Usia. Jakarta: Badan Pusat Statistik; 2022.

Akhmad A, Sahmad S, Hadi I, Rosyanti L. Mild cognitive impairment (MCI) pada aspek kognitif dan tingkat kemandirian lansia dengan mini-mental state examination (MMSE). Health Inf J Penelit 2019;11:48–58. doi: 10.36990/hijp.v11i1.105.

Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet 2017;390:2673–734. doi: 10.1016/S0140-6736(17)31363-6.

Chien DT, Bahri S, Szardenings AK, et al. Early clinical PET imaging results with the novel PHF-Tau Radioligand [F-18]-T807. J Alzheimers Dis 2013;34:457–68. doi: 10.3233/JAD-122059.

Fleisher AS, Chen K, Quiroz YT, et al. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. JAMA Neurol 2015;72:316. doi: 10.1001/jamaneurol.2014.3314.

Xia MH, Li A, Gao RX, et al. Research hotspots and trends of multimodality MRI on vascular cognitive impairment in recent 12 years: a bibliometric analysis. Medicine (Baltimore) 2022;101:e30172. DOI: 10.1097/MD.0000000000030172.

Herrera-Franco G, Montalván-Burbano N, Carrión-Mero P, Jaya-Montalvo M, Gurumendi-Noriega M. Worldwide research on geoparks through bibliometric analysis. Sustainability 2021;13:1175. doi: 10.3390/su13031175.

Cancino CA, Merigo JM, Coronado FC. Big names in innovation research: a bibliometric overview. Curr Sci 2017;113:1507. doi: 10.18520/cs/v113/i08/1507-1518.

van Eck NJ, Waltman L. Visualizing bibliometric networks. In: Ding Y, Rousseau R, Wolfram D, editors. Measuring scholarly impact. Cham (Switzerland): Springer International Publishing; 2014.p. 285–320.

Ronoatmojo IS, Apriniyadi M, Nugraheni RD, Riyandhani CP, Rosyidan CR, Sutadiwiria Y. Bibliometric analysis on numerical lithofacies identification for reservoir characterization in the period of 1980 - 2021. J Petro 2022;XI:163–72. doi: 10.25105/petro.v11i4.14424.

Casprini E, Dabic M, Kotlar J, Pucci T. A bibliometric analysis of family firm internationalization research: current themes, theoretical roots, and ways forward. Int Bus Rev 2020;29:101715. doi: 10.1016/j.ibusrev.2020.101715.

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8. doi: 10.1001/archneur.56.3.303.

Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94. doi: 10.1111/j.1365-2796.2004.01388.x.

Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89. doi: 10.1006/nimg.2001.0978.

Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:270–9. doi: 10.1016/j.jalz.2011.03.008.

Fischl B. FreeSurfer. Neuroimage 2012;62:774–81. doi: 10.1016/j.neuroimage.2012.01.021.

Rathore S, Habes M, Iftikhar MA, Shacklett A, Davatzikos C. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer’s disease and its prodromal stages. Neuroimage 2017;155:530–48. doi: 10.1016/j.neuroimage.2017.03.057.

Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:280–92. doi: 10.1016/j.jalz.2011.03.003.

Belleville S, Gauthier S, Lepage E, Kergoat MJ, Gilbert B. Predicting decline in mild cognitive impairment: a prospective cognitive study. Neuropsychology 2014;28:643–52. doi: 10.1037/neu0000063.

Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014;13:614–29. doi: 10.1016/S1474-4422(14)70090-0.

Besson FL, La Joie R, Doeuvre L, et al. Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer’s disease. J Neurosci 2015 ;35:10402–11. doi: 10.1523/JNEUROSCI.0150-15.2015.

Mejia C, Wu M, Zhang Y, Kajikawa Y. Exploring topics in bibliometric research through citation networks and semantic analysis. Front Res Metr Anal 2021;6:742311. doi: 10.3389/frma.2021.742311.

Li XL, Gao RX, Zhang Q, et al. A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science. Medicine (Baltimore) 2022;101:e30079. doi: 10.1097/MD.0000000000030079.

Vipin A, Satish V, Saffari SE, et al. Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease. Alzheimers Res Ther 2021;13:195. doi: 10.1186/s13195-021-00936-y.

Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CLH. Prevalence, risk factors and consequences of cerebral small vessel diseases: data fom three Asian countries. J Neurol Neurosurg Psychiatry 2017;88:669–74. doi: 10.1136/jnnp-2016-315324.

Potashman M, Gillis J, Mirzaei F, Maserejian N. PND21 - the prevalence of mild cognitive impairment: a systematic review and data synthesis. Value Health 2018;21:S332–3. doi: 10.1016/j.jval.2018.09.198.8

Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimers Dis 2021;1–16. doi: 10.14283/jpad.2021.23.

Sachdev PS, Lo JW, Crawford JD, et al. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimers Dement Amst Neth 2017;7:11–23. doi: 10.1016/j.dadm.2016.10.006.

Deng Y, Zhao S, Cheng G, et al. The prevalence of mild cognitive impairment among Chinese people: a meta-analysis. Neuroepidemiology 2021;55:79–91. doi: 10.1159/000512597.

Hussin NM, Shahar S, Yahya HM, Din NC, Singh DKA, Omar MA. Incidence and predictors of mild cognitive impairment (MCI) within a multi-ethnic Asian populace: a community-based longitudinal study. BMC Public Health 2019;19:1159. doi: 10.1186/s12889-019-7508-4.

Sachdev PS, Lipnicki DM, Kochan NA, et al. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC Collaboration. PLoS One 2015;10:e0142388. doi: 10.1371/journal.pone.0142388.

Lu Y, Liu C, Yu D, et al. Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review. BMC Geriatr 2021;21:10. doi: 10.1186/s12877-020-01948-3.

Ishikawa KM, Davis J, Chen JJ, Lim E. The prevalence of mild cognitive impairment by aspects of social isolation. PLoS One 2022;17:e0269795. doi: 10.1371/journal.pone.0269795.

Teh WL, Abdin E, Vaingankar JA, et al. Prevalence, lifestyle correlates, and psychosocial functioning among multi-ethnic older adults with mild cognitive impairment in Singapore: preliminary findings from a 10/66 Population Study. Yale J Biol Med 2021;94:73–83.

Patro SN, Glikstein R, Hanagandi P, Chakraborty S. Role of neuroimaging in multidisciplinary approach towards non-Alzheimer’s dementia. Insights Imaging 2015;6:531–44. doi: 10.1007/s13244-015-0421-1.

Zucchella C, Sinforiani E, Tamburin S, et al. The multidisciplinary approach to Alzheimer’s disease and dementia: a narrative review of non-pharmacological treatment. Front Neurol ;9:1058. doi: 10.3389/fneur.2018.01058.

Blackman J, Swirski M, Clynes J, Harding S, Leng Y, Coulthard E. Pharmacological and non pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer’s disease: a systematic review. J Sleep Res 2021;4: e13229. doi: 10.1111/jsr.13229..

Fink HA, Jutkowitz E, McCarten JR, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med 2018;168:39. doi: 10.7326/M17-1529.

Lee GE, Kim JY, Jung JH, Kang HW, Jung IC. Non-pharmacological interventions for patients with dementia: a protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e17279. doi: 10.1097/MD.0000000000017279.

Galvin JE, Valois L, Zweig Y. Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag 2014;4:455–69. doi: 10.2217/nmt.14.47.

Heintz H, Monette P, Epstein-Lubow G, Smith L, Rowlett S, Forester BP. Emerging collaborative care models for dementia care in the primary care setting: a narrative review. Am J Geriatr Psychiatry 2020;28:320–30. doi: 10.1016/j.jagp.2019.07.015.

Nieuwboer MS, Richters A, van der Marck MA. Triple aim improvement for individuals, services and society in dementia care: the dementianet collaborative care approach. Z Gerontol Geriatr 2017;50(Suppl 2):78–83. doi: 10.1007/s00391-017-1196-4.

Samus QM, Black BS, Bovenkamp D, et al. Home is where the future is: the BrightFocus Foundation consensus panel on dementia care. Alzheimers Dement 2018;14:104–14. doi: 10.1016/j.jalz.2017.10.006.

Schindler SE. Fluid biomarkers in dementia diagnosis. Contin Lifelong Learn Neurol 2022 ;28:822–33. doi: 10.1212/CON.0000000000001083.

Ruan Q, D’Onofrio G, Sancarlo D, Bao Z, Greco A, Yu Z. Potential neuroimaging biomarkers of pathologic brain changes in mild cognitive impairment and Alzheimer’s disease: a systematic review. BMC Geriatr 2016;16:104. doi: 10.1186/s12877-016-0281-7.

Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160–3; discussion 1167. doi: 10.1001/archneur.62.7.1160.

Petersen LE, Hammon J, McCormick J, Petersen RC. Cognitive aging research at Mayo Clinic. Minn Med 2002;85:29–31. doi: 10.1001/archneur.62.7.1160.

Petersen RC. New clinical criteria for the Alzheimer’s disease spectrum. Minn Med 2012;95:42–5.

Baker DJ, Petersen RC. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Inves. 2018 2;128:1208–16. doi: 10.1172/JCI95145.

Jack CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013;12:207–16. doi: 10.1016/S1474-4422(12)70291-0.

Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018;90:126–35. doi: 10.1212/WNL.0000000000004826.

Petersen RC, Graf A, Carrillo MC, Weber CJ. Current understanding of AD pathophysiology and impact of amyloid-beta targeted treatments on biomarkers and clinical endpoints. Alzheimers Dement (NY) 2022;8:e12361. doi: 10.1002/trc2.12361

Nie D, Shen D. Adversarial confidence learning for medical image segmentation and synthesis. Int J Comput Vis 2020;128:2494–513. doi: 10.1007/s11263-020-01321-2.

Zhou T, Thung KH, Liu M, Shi F, Zhang C, Shen D. Multi-modal latent space inducing ensemble SVM classifier for early dementia diagnosis with neuroimaging data. Med Image Anal 2020;60:101630. doi: 10.1016/j.media.2019.101630.

Xue Z, Shen D, Davatzikos C. CLASSIC: consistent longitudinal alignment and segmentation for serial image computing. Inf Process Med Imaging 2005;19:101–13. doi: 10.1007/11505730_9.

Blennow K, Zetterberg H. Biomarkers for Alzheimer’s disease: current status and prospects for the future. J Intern Med 2018;284:643–63. doi: 10.1111/joim.12816.

Knopman DS, Petersen RC. Mild cognitive impairment and mild dementia: a clinical perspective. Mayo Clin Proc 2014;89:1452–9. doi: 10.1016/j.mayocp.2014.06.019.

Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet 2021 ;397:1577–90. doi: 10.1016/S0140-6736(20)32205-4.

Klunk WE, Koeppe RA, Price JC, et al. The Centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 2015;11:1-15.e1-4. doi: 10.1016/j.jalz.2014.07.003.

Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol 2017;13:217–31. doi: 10.1038/nrneurol.2017.27.